STOCK TITAN

Atlanta Braves Holdings, Inc. Series C Form 4 Filings

BATRK NASDAQ

Every Form 4 that Atlanta Braves Holdings, Inc. Series C (BATRK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow BATRK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BATRK filings page.

Rhea-AI Summary

Atlanta Braves Holdings, Inc. EVP, Business Derek Gordon Schiller exercised options to acquire 175,395 Series C Common Stock shares at an exercise price of $27.18 per share on September 30, 2026, then sold 175,395 shares at a weighted average price of $53.20 per share. The sale prices ranged from $52.41 to $54.10 per share. The sale was made under a Rule 10b5-1 sales plan adopted June 30, 2026.

Rhea-AI Summary

Atlanta Braves Holdings, Inc. executive Gregory John Heller, EVP, CLO & Secretary, exercised options covering 80,263 Series C Common Stock shares at an exercise price of $27.18 per share on September 29, 2026, then sold 80,263 shares at a weighted-average price of $53.89 per share. The sale was effected under a Rule 10b5-1 sales plan adopted on June 30, 2026.

Rhea-AI Summary

Atlanta Braves Holdings, Inc. (BATRA/BATRK) reported insider transactions by Jill L. Robinson, EVP, CFO & Treasurer. On August 19, 2026, she exercised options for 30,263 shares of Series C Common Stock at an exercise price of $27.18 per share and then sold 30,263 shares at a weighted average price of $52.84 per share, under a Rule 10b5-1 sales plan adopted on May 18, 2026.

Rhea-AI Summary

Atlanta Braves Holdings, Inc. insider group GAMCO-related reporting persons disclosed activity in Series A Common Stock. The filing shows an open-market sale of 500 shares on March 2, 2026 at $48.20 per share, leaving 11,500 shares in that direct account. Additional lines list direct and indirect holdings totaling 42,000, 27,152, and 15,000, 12,500, 20,000, and 2,800 shares held through various investment partnerships. Footnotes state that certain positions are owned by Associated Capital Group, Inc., GGCP, Inc., and Mario J. Gabelli, and clarify that the securities reported exceed the reporting persons’ indirect pecuniary interests, which they disclaim beyond their actual economic stake.

Rhea-AI Summary

Atlanta Braves Holdings, Inc. insider John C. Malone, a ten percent owner, rebalanced his holdings between share classes in a private, related-party exchange on February 25, 2026. He acquired 10,868 shares of Series B Common Stock from two trusts whose beneficiaries are his adult children. In return, he contributed an aggregate 14,614 shares of Series C Common Stock and $42.18 in cash to those trusts.

Following these transactions, Malone directly held 14,537 shares of Series B Common Stock and 2,662,534 shares of Series C Common Stock. He also reported additional indirect holdings of Series B and Series C shares through entities including JCM AB LLC, the John C. Malone June 2003 Charitable Remainder Unitrust, and the Leslie A. Malone 1995 Revocable Trust.

Rhea-AI Summary

Atlanta Braves Holdings, Inc. executive Jill L. Robinson, EVP, CFO & Treasurer, exercised options for 60,000 shares of Series C Common Stock at a stated exercise price of $0.0000 per share and acquired the underlying stock at $27.1800 per share. She then sold 60,000 Series C shares on the same day at $42.0000 per share in an open-market transaction.

After these transactions, she directly owned 79,460 Series C Common shares and 30,263 stock options. The sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2025.

Rhea-AI Summary

John C. Malone, a 10% owner of Atlanta Braves Holdings, Inc., reported open-market-like purchases of the company’s common stock. On February 5, 2026, he acquired 35,000 shares of Series A Common Stock at a weighted average price of $44.23, bringing his direct Series A holdings to 521,862 shares. On February 4, 2026, he purchased 3,669 shares of Series B Common Stock in a private transaction at $48.17, and now directly holds 3,669 Series B shares. He also has indirect exposure through entities: 887,079 Series B shares are held by JCM AB LLC, and 10,177 Series A and 47,585 Series B shares are held by the Leslie A. Malone 1995 Revocable Trust, for which he disclaims beneficial ownership.

Rhea-AI Summary

Atlanta Braves Holdings executive Jill L. Robinson exercised stock options and sold shares of Series C Common Stock. On 02/02/2026, she exercised options for 20,000 BATRK shares at an exercise price of $27.18 per share and received 20,000 shares.

That same day, she sold 20,000 Series C Common shares at a weighted average price of $40.00 per share, within a range of $39.71 to $40.22, under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2025. After these transactions, she directly owned 79,460 Series C Common shares and held 90,263 stock options.